Todd Pappas
Vice President of Research and Development at Aspira Women's Health- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Experience
-
Aspira Women's Health
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Vice President of Research and Development
-
Aug 2023 - Present
Austin, Texas, United States
-
-
Senior Director of Research and Development
-
Aug 2022 - Aug 2023
Austin, Texas, United States
-
-
Development Scientist
-
Dec 2013 - Aug 2023
Austin, Texas - Lead ongoing research and development programs with academic scientific collaborators - Provide R&D and Validation content for regulatory submission - FDA 510(k) Submission for IVD - Development and Validation of IVDMIA - Discovery of Protein Biomarkers for Women's Health
-
-
Director of Research and Development
-
Oct 2015 - Dec 2017
-
-
-
calliope llc
-
United States
-
Advertising Services
-
1 - 100 Employee
-
Principal
-
Aug 2013 - Present
Austin, Texas Area Consulting for IVD product development, oncology, quality Real-world data statistical analysis and evidence generation
-
-
-
Delphi Inc
-
Canada
-
Individual and Family Services
-
Chief Commercialization Officer, Director of Clinical Operations
-
Jul 2017 - Dec 2020
Austin, Texas Area Develop the strategic, clinical, and technical plan for novel breast cancer diagnostics that inform therapeutic decisions
-
-
-
Reliant Immune Diagnostics
-
United States
-
Research Services
-
Vice President of Clinical and Regulatory Affairs
-
May 2019 - May 2020
Austin, Texas Area Reliant is a Healthcare Technology Company integrating diagnostic technologies and user experience to improve telemedicine
-
-
-
Luminex Corporation
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Director of R&D, Biodefense and Food Safety
-
Jan 2012 - Aug 2013
Austin, Texas Area - Directed instrumentation and assay discovery and development on $11 million DTRA R&D contract - Directed NIH-funded research on novel assays for Ebola virus variant detection - Directed internally funded research on nucleic acid and protein detection assays for diagnostics and biosurveillance
-
-
Extramural Grants Manager
-
Jun 2010 - Jan 2012
- Developed, wrote and received funding for $11 Million DTRA R&D contract for diagnostic instruments and assays. - Developed, wrote and received funding for $3 million NIH R01 Grant for Ebola virus immunodiagnostic assay discovery and development. - Wrote numerous white papers for technology development - Developed statements of work and budgets - Managed post-award process including developing subawards, - Experience with NIH, Gates Foundation, DARPA, DTRA… Show more - Developed, wrote and received funding for $11 Million DTRA R&D contract for diagnostic instruments and assays. - Developed, wrote and received funding for $3 million NIH R01 Grant for Ebola virus immunodiagnostic assay discovery and development. - Wrote numerous white papers for technology development - Developed statements of work and budgets - Managed post-award process including developing subawards, - Experience with NIH, Gates Foundation, DARPA, DTRA, BARDA, DHS
-
-
-
Asuragen
-
United States
-
Biotechnology
-
100 - 200 Employee
-
Scientific Writer
-
Apr 2007 - Jun 2010
-
-
-
Grant Writing support
-
Business Consulting and Services
-
Consultant
-
2009 - 2009
-
-
Education
-
The University of Texas Medical Branch
Ph.D., Neuroscience -
California State University, Long Beach
MS, Behavioral Biology -
Loyola Marymount University
BS, Biology, General